ArticleAmerican journal of clinical dermatology2024

Clinical Efficacy and Safety of Interleukin-17 Inhibitors in Treating Patients with Erythrodermic Psoriasis: A Retrospective Cohort, Three-Center Study.

Yu Lan et al.PubMed ↗Publisher ↗

No numbers read from the abstract.